A detailed history of Raelipskie Partnership transactions in Johnson & Johnson stock. As of the latest transaction made, Raelipskie Partnership holds 13,428 shares of JNJ stock, worth $1.94 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares
13,428
Previous 13,690 1.91%
Holding current value
$1.94 Million
Previous $2 Billion 8.76%
% of portfolio
1.06%
Previous 1.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$145.48 - $167.38 $38,115 - $43,853
-262 Reduced 1.91%
13,428 $2.18 Billion
Q2 2024

Jul 18, 2024

SELL
$144.38 - $157.78 $57,752 - $63,112
-400 Reduced 2.84%
13,690 $2 Billion
Q1 2024

May 23, 2024

BUY
$155.22 - $162.74 $82,421 - $86,414
531 Added 3.92%
14,090 $2.23 Billion
Q4 2023

May 23, 2024

BUY
$145.6 - $158.88 $1.97 Million - $2.15 Million
13,559 New
13,559 $2.13 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Raelipskie Partnership Portfolio

Follow Raelipskie Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raelipskie Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Raelipskie Partnership with notifications on news.